Abstract
The discovery of novel biologically active small molecules is now a technologically and economically viable proposition for academic and small biotechnology laboratories wishing to build on their biological research into target proteins. Such small molecules may be useful reagents for further biological research or may form the basis for early-stage drug discovery. The availability of specialized virtual screening software to filter large molecular libraries into manageable numbers of compounds for biological assays is the driving force for finding novel ligands. The main focus of this chapter is the basis and use of molecular field methods to assess the interactions that may be made by small molecules. Molecular field based measures of capability and similarity of interaction may be used to discover novel ligands and expand ligand series for potential use as future therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nicholls A (2011) What do we know? Simple statistical techniques that help. In: Bajorath J (ed) Chemoinformatics and computational chemical biology. Springer Science, New York
Merz KM et al (2010) Drug design structure- and ligand-based approaches. CUP, Cambridge
Leach AR (2001) Molecular modelling: principles and applications, 2nd edn. Longman, Edinburgh
Gasteiger J, Engel T (2004) Chemoinformatics: a textbook. Wiley, Wienheim
Young DC (2009) Computational drug design: a guide for computational and medicinal chemists. Wiley, New Jersey
Rigby M et al (1986) The forces between molecules. OUP, Oxford
Stone AJ (2008) Intermolecular potentials. Science 321:787–789
Bissantz C, Kuhn B, Stahl M (2010) A medicinal chemist’s guide to molecular interactions. J Med Chem 53:5061–5084
Chan AW, Laskowski RA, Selwood DL (2010) Chemical fragments that hydrogen bond to Asp, Glu, Arg and His sidechains in protein binding sites. J Med Chem 53:3086–3094
Protein DataBank (PDB) at RCSB: http://www.rcsb.org/
Williams MA, Ladbury JE (2003) Hydrogen bonds in protein–ligand complexes. In: Böhm HJ, Schneider G (eds) Protein–ligand interactions from molecular recognition to drug design. Wiley, Weinheim
Gilli G, Gilli P (2009) The nature of the hydrogen bond: outline of a comprehensive hydrogen bond theory. OUP, Oxford
Labowski SJ (2006) Hydrogen bonding: new insights. Springer, Netherlands
Foloppe N (2005) Structure-based design of novel Chk1 inhibitors: Insights into hydrogen bonding and protein–ligand affinity. J Med Chem 48:4332–4345
Kubinyi H (2008) The changing landscape in drug discovery. In: Stroud RM, Finer-Moore J (eds) Computational and structural approaches to drug discovery. RSC, Cambridge
Parisini E et al (2011) Halogen bonding in halocarbon–protein complexes: a structural survey. Chem Soc Rev 40:2267–2278
Riley KE, Hobza P (2011) Strength and character of halogen bonds in protein–ligand complexes. Cryst Growth Des 11:4272–4278
Hunter CA, Sanders JKM (1990) The nature of π–π Interactions. J Am Chem Soc 112:5525–5534
Tsuzuki S (2005) Interactions with aromatic rings. Struc Bond 115:149–193
Gooding M (2011) Exploring the interaction between siRNA and the SMoC biomolecule transporters: implications for small molecule-mediated delivery of siRNA. Chem Biol Drug Des 79:9–21
Lanzarotti E (2011) Aromatic–aromatic interactions in proteins: beyond the dimer. J Chem Inf Model 51:1623–1633
Barron LD, Hecht L, Wilson G (1997) The lubricant of life: a proposal that solvent water promotes extremely fast conformational fluctuations in mobile heteropolypeptide structure. Biochemistry 36:13143–13147
Setny P, Baron R, McCammon JA (2010) How can hydrophobic association be enthalpy driven? J Chem Theory Comput 6:2866–2871
Myslinski JM et al (2011) Protein–ligand interactions: thermodynamic effects associated with increasing nonpolar surface area. J Am Chem Soc 133:18518–18521
Hassan SA et al (2005) Computer simulation of protein–ligand interactions: challenges and applications. In: Nienhaus GU (ed) Protein–ligand Interactions. Humana, New Jersey
Schmidtke P et al (2011) Shielded hydrogen bonds as structural determinants of binding kinetics: application in drug design. J Am Chem Soc 133:18903–18910
Cavasotto CN, Phatak SS (2011) Docking methods for structure-based library design. In: Zhou JZ (ed) Chemical library design. Springer, New York
Irwin JJ, Shoichet BK (2005) ZINC – a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177–182
Li R et al (2011) Development of a method to consistently quantify the structural distance between scaffolds and to assess scaffold hopping potential. J Chem Inf Model 57:2507–2514
Wermuth CG (2008) The practice of medicinal chemistry. Academic, London
Low CMR (2005) Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists. J Med Chem 48:6790–6802
Warwicker J (1994) Improved continuum electrostatic modelling in proteins, with comparison to experiment. J Mol Biol 236:887–903
Apaya RP (1995) The matching of electrostatic extrema: a useful method in drug design? A study of phosphodiesterase III inhibitors. J Comput Aided Mol Des 9:33–43
Bruno IJ et al (1997) Isostar: a library of information about non-bonded interactions. J Comput Aided Mol Des 11:525–537, http://www.ccdc.cam.ac.uk/products/csd_system/isostar/
Cresset software http://www.cresset-group.com
Vinter JG (1994) Extended electron distributions applied to molecular mechanics of intermolecular interactions. J Comput Aided Mol Des 8:653–668
Cheeseright T et al (2006) Molecular field extrema as descriptors of biological activity: definition and validation. J Chem Inf Model 46:665–676
Goodford PJ (1985) A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem 28:849–857
OpenEye http://www.eyesopen.com/
MOE (Molecular Operating Environment) http://www.chemcomp.com/software.htm
Gane PJ, Chan E, Selwood D. ChemiBank http://www.ucl.ac.uk/chemibank
John Hopkins clinical collection http://htc.wustl.edu/library/JHCCL.html
Mol2 format http://tripos.com/tripos_resources/fileroot/pdfs/mol2_format.pdf
Rishton GM (2003) Non-leadlikeness and leadlikeness in biochemical screening. DDT 8:86–96
Acknowledgments
OpenEye for free access to their full suite of programs, MOE and GOLD for their generous academic pricing, Cresset for their free teaching licenses and support. Andy Vinter and Martin Slater for their excellent advice.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Gane, P.J., Chan, A.W.E. (2013). Molecular Fields in Ligand Discovery. In: Williams, M., Daviter, T. (eds) Protein-Ligand Interactions. Methods in Molecular Biology, vol 1008. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-398-5_18
Download citation
DOI: https://doi.org/10.1007/978-1-62703-398-5_18
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-397-8
Online ISBN: 978-1-62703-398-5
eBook Packages: Springer Protocols